呼吸(肺腺癌转移与首发症状联系).pptxVIP

资料来源：指南以及医学期刊 肺腺癌的转移与首发症状的联系 ASCO: Molecular Testing for All LungAdenocarcinomas ASCO：对肺腺癌患者的分子评估 Nick Mulcahy October 13, 2014 A guidelinan Society of Clinical Oncology (ASCO) and published online today in theJournal of Clinical Oncology. ASCO最近认可了一项指南，该指南中确定了哪些肺癌患者需要进行分子学测试评估，指南发表在临床肿瘤学杂志10月13日的在线期刊上。 Most notably, the guideline states that allpatients with lung adenocarcinoma (or mixed lung cancers with an adenocarcinomacomponent) should undergo testing for epidermal growth factor receptor (EGFR)and anaplastic lymphoma kinase (ALK). 该指南中，最显著的是陈述了所有的肺腺癌（或具有肺腺癌成分的混合肺癌）患者都应该接受表皮生长因子受体（EGFR）和间